Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

Amgen (NASDAQ:AMGN – Get Free Report) is expected to be issuing its quarterly earnings data after the market closes on ...

Amgen (NASDAQ:AMGN – Free Report) had its price target decreased by Citigroup from $310.00 to $295.00 in a research report released on Tuesday morning,Benzinga reports. Citigroup currently has a ...

The biotech is, however, facing one of the steepest patent cliffs in the biopharma industry, with $4.35 billion TNF inhibitor Enbrel (etanercept) and $2.25 billion psoriasis therapy Otezla ...

With the overall stock market very overbought, the four highest-yielding Dogs of the Dow look like outstanding ideas now.

Q: Is Laapataa Ladies Flop or Hit? A: The performance of Laapataa Ladies was Average. Q: What is the overall Box Office Collection of Laapataa Ladies? A:Laapataa Ladies collected ₹25.26 cr.

Amgen has won FDA approval for a stronger label for its oral plaque psoriasis therapy Otezla, as it prepares for competition from Bristol-Myers Squibb's much-touted rival deucravacitinib ...